News Sentiment

SNOA sentiment intelligence

Sonoma Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1.26 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

87/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+4.1% over one week, +15.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Enterprise value to revenue forward of Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 87/100 classification
One-week reaction 4.1% Price confirming higher
Trend fit Trend inactive 15.6% over four weeks
Fair value -72.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 32
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 7
Stock Titan 5
Market source 5
TradingKey 5
Investing.com 3
Investing.com South Africa 1
Voice of Alexandria 1
MT Newswires 1

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 5
Guidance 2
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40
TradingView Direct company coverage

Price to sales forward of Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA

This page provides the "Price to sales forward" financial metric for Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA). The content is primarily a placeholder or incomplete financial data page from TradingView, indicating that the value for this metric is not currently available or dis

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 10:10
Source
TradingView
Investing.com South Africa Direct company coverage

Form 4 Sonoma Pharmaceuticals Inc For: 9 July By Investing.com

This article announces the filing of a Form 4 for Sonoma Pharmaceuticals Inc (SNOA) on July 9, as reported by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 08:11
Source
Investing.com South Africa
TradingView Direct company coverage

Enterprise value to EBIT forward of Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA

This article provides financial data for Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA), specifically focusing on its enterprise value to EBIT forward. It indicates basic financial overview information for the company as found on TradingView, noting that the market was closed at the

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 01:11
Source
TradingView
Stock Titan Direct company coverage

Sonoma Pharmaceuticals (NASDAQ: SNOA) awards CEO 10,000 RSUs in equity grant

Sonoma Pharmaceuticals (NASDAQ: SNOA) has granted its CEO, Amy Moss Trombly, 10,000 Restricted Stock Units (RSUs) as compensation for services. These RSUs will vest on the third anniversary of the grant date or upon a change of control. After this award, Ms. Trombly holds a total

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 01:11
Source
Stock Titan
Stock Titan Direct company coverage

Sonoma Pharmaceuticals (SNOA) CFO receives 10,000 RSU equity award in new grant

Sonoma Pharmaceuticals' CFO, Jerome J. Dvonch, was granted 10,000 Restricted Stock Units (RSUs) as part of his compensation. These RSUs represent a contingent right to an equal number of common shares and increase his total shares-related units to 44,391. The RSUs are set to vest

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 01:11
Source
Stock Titan
TradingView Direct company coverage

Price to sales forward of Sonoma Pharmaceuticals, Inc. – FWB:O8Z

This page from TradingView displays financial information for Sonoma Pharmaceuticals, Inc. listed on the Frankfurt Stock Exchange under the ticker FWB:O8Z. Specifically, it focuses on the "Price to sales forward" metric for the company. The page indicates that the market is curre

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 19:16
Source
TradingView
Market source Direct company coverage

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn® Wound Irrigation Solution

Sonoma Pharmaceuticals, Inc. announced it received FDA 510(k) clearance for its Microdacyn® Wound Irrigation Solution, expanding its approved uses to include cleansing, irrigation, debridement of various acute and chronic dermal lesions, and OTC management of minor skin abrasions

Tone
Positive 70/100
Event
Market update
Published
01 Jul 2026 21:10
Source
Market source
Stock Titan Direct company coverage

FDA clears Sonoma’s Microdacyn for more wound uses, new packs

Sonoma Pharmaceuticals has received new FDA 510(k) clearance for its Microdacyn® Wound Irrigation Solution, expanding its indications, usage, and packaging options. The clearance allows for broader professional wound applications, over-the-counter use for minor skin issues, singl

Tone
Positive 74/100
Event
Market update
Published
01 Jul 2026 07:09
Source
Stock Titan
Voice of Alexandria Direct company coverage

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) has announced it received a new 510(k) clearance from the FDA for its Microdacyn® Wound Irrigation Solution. This clearance expands the product's indications to include a wider range of acute and chronic dermal lesions, allows for multip

Tone
Positive 93/100
Event
Market update
Published
30 Jun 2026 18:41
Source
Voice of Alexandria
Investing.com Direct company coverage

Sonoma Pharmaceuticals receives FDA clearance for wound solution

Sonoma Pharmaceuticals has received 510(k) clearance from the FDA for its Microdacyn Wound Irrigation Solution, expanding its claims and introducing new packaging options. This clearance allows broader use for wound care under healthcare supervision and for minor skin abrasions o

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 14:09
Source
Investing.com
TradingView Direct company coverage

Sonoma Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:SNOA)

This article provides an overview of Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) stock performance, financial data, and analyst estimates. It details the company's current stock price, historical highs and lows, volatility, and upcoming earnings report. The piece also includes in

Tone
Negative 39/100
Event
Earnings
Published
26 Jun 2026 03:41
Source
TradingView
TradingKey Direct company coverage

Sonoma Pharmaceuticals Inc (SNOA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Sonoma Pharmaceuticals Inc (SNOA), detailing its price momentum, support and resistance levels, and indicator and moving average readings. Currently, SNOA has a price momentum score of 3.83, trading between a resistance of $1.26 and a

Tone
Negative 29/100
Event
Market update
Published
23 Jun 2026 05:09
Source
TradingKey
TipRanks Direct company coverage

Sonoma Pharmaceuticals Expands At-the-Market Equity Offering Capacity

Sonoma Pharmaceuticals recently announced an increase in its at-the-market equity offering capacity to $3.64 million, providing greater flexibility for accessing equity capital. The company previously sold 173,073 shares, raising $574,633 through a sales agreement with Ladenburg

Tone
Neutral 50/100
Event
Market update
Published
21 Jun 2026 07:40
Source
TipRanks
Bitget Direct company coverage

According to a recent filing submitted to the U.S. Securities and Exchange Commission (SEC), Sonoma Pharmaceuticals, Inc. has raised the maximum total offering price of its common stock issuance to $3.64 million.

Sonoma Pharmaceuticals, Inc. has increased the maximum total offering price of its common stock issuance to $3.64 million, as revealed in an SEC filing. This adjustment is intended to provide the company with more flexibility for future financing activities, which market analysts

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 13:10
Source
Bitget
Investing.com Direct company coverage

Sonoma Pharmaceuticals increases at-the-market offering to $3.64 million

Sonoma Pharmaceuticals announced an increase in its at-the-market (ATM) equity program to an aggregate offering price of $3.64 million, reflected in a recent SEC filing. This move comes as the company navigates financial challenges and follows the sale of 173,073 shares for gross

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 03:09
Source
Investing.com
TradingView Direct company coverage

Sonoma Pharmaceuticals boosts shelf offering capacity to $3.64M after prior $574.6K sales

Sonoma Pharmaceuticals (SNOA) has increased its at-the-market offering capacity to $3.64 million. The company has already sold 173,073 shares, generating $574,633, between September 2025 and June 2026. This move includes previously registered but unsold shares, and the company ha

Tone
Positive 63/100
Event
Market update
Published
19 Jun 2026 00:00
Source
TradingView
TradingKey Direct company coverage

Sonoma Pharmaceuticals Inc

This article provides a revenue breakdown for Sonoma Pharmaceuticals Inc (SNOA) by business segment and geographical region, as of the third quarter of fiscal year 2026. The company's revenue is primarily driven by its Human Care segment, which accounts for 88.83% of total revenu

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 21:40
Source
TradingKey
Stock Titan Direct company coverage

[8-K] Sonoma Pharmaceuticals, Inc. Reports Material Event

Sonoma Pharmaceuticals, Inc. (SNOA) has reported an update to its "at-the-market" stock offering program. The company increased its aggregate offering price capacity to $3,641,703 under a Form S-3 shelf registration, filing a supplement to its prospectus. Previously, Sonoma Pharm

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 20:40
Source
Stock Titan
TradingKey Direct company coverage

Sonoma Pharmaceuticals Inc (SNOA) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Sonoma Pharmaceuticals Inc (SNOA), noting its current valuation score of 9.48, ranking 19 out of 157 in the Pharmaceuticals industry. It highlights the company's P/E ratio of -0.59, which is significantly below its recent high and abo

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 09:39
Source
TradingKey
TradingKey Direct company coverage

Sonoma Pharmaceuticals Inc (SNOA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sonoma Pharmaceuticals Inc (SNOA), outlining major individual and institutional holdings. It lists key shareholders like DRW Securities, Vanguard Capital Management, and Geode Capital Management, along with their respective propor

Tone
Negative 42/100
Event
Market update
Published
18 Jun 2026 09:39
Source
TradingKey
TradingKey Direct company coverage

Sonoma Pharmaceuticals Inc (SNOA) Institutional Confidence

This article provides details on the institutional confidence score for Sonoma Pharmaceuticals Inc (SNOA) as of June 18, 2026. It lists key institutional shareholders and their recent activity, showing changes in shares held by various entities. The institutional confidence score

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:09
Source
TradingKey